From Germ Cell Tumor to Acute Promyelocytic Leukemia: A Dual Malignancy Following Topoisomerase II Inhibitor–Containing Chemotherapy
Authors:
- Tejasvi SharmaTSTejasvi Sharma
- Mansi SharmaMSMansi Sharma
- Abhishek PurohitAPAbhishek Purohit
- Rakesh ChoudharyRCRakesh Choudhary
- Eveeta BaruahEBEveeta Baruah
- Niharika SinghNSNiharika Singh
- Gopal Krishana BohraGBGopal Krishana Bohra
- 19 June 2026
- journal article
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Therapy-related acute promyelocytic leukemia: a systematic reviewMedical Oncology, 2013
- Clinical and Pathologic Features of Secondary Acute Promyelocytic LeukemiaAmerican Journal of Clinical Pathology, 2012
- Therapy‐related acute promyelocytic leukemia: observations relating to APL pathogenesis and therapy*European Journal of Haematology, 2011
- Outcome of therapy‐related acute promyelocytic leukemia with or without arsenic trioxide as a component of frontline therapyCancer, 2010
- Morphologic, Cytogenetic, and Molecular Abnormalities in Therapy-Related Acute Promyelocytic LeukemiaAmerican Journal of Clinical Pathology, 2005
- Secondary leukemia after first-line high-dose chemotherapy for patients with advanced germ cell cancerJournal of Cancer Research and Clinical Oncology, 2004